Pet Cancer Therapeutics Market: Size, Share, Trends, Global Opportunity Analysis and Forecast, 2025 | Karyopharm Therapeutics, Inc., Regeneus Ltd., Rhizen Pharmaceuticals SA, Oasmia Pharmaceuticals AB, and Zoetis.
Pet Cancer Therapeutics The diagnostic and therapy options for malignant and tumour growth in domesticated animals are referred to as pet cancer therapies. It treats lymphoma, mast cell cancer, melanoma, mammary and squamous cell cancer in dogs, cats, and other pets. Chemotherapy, immunotherapy, radiation treatment, and biopsy are some of the most often utilised therapies. These treatments use plant- and bacteria-based medications to gradually destroy or shrink cancer cells, preventing the tumour from spreading to other regions of the body. Orally or intravenously, the medications are injected under the skin, into a muscle, or into the tumour. They're added to food or treats to conceal the taste and make it more enticing to dogs. Due to increased consumer expenditure on pet healthcare, the pet cancer therapeutics market is expected to rise significantly. People are getting more concerned about their pets' health and spending more money on the greatest animal therapies acces...